English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Allergan, Inc.
Ruth de Jauregui
| Apr 22, 2017
Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming
| Jan 24, 2017
Allergan continues support for headache research
Jamie Barrand
| Mar 20, 2016
New treatment available for bipolar disorder, schizophrenia
Jamie Barrand
| Mar 17, 2016
Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand
| Dec 17, 2015
Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand
| Dec 7, 2015
Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand
| Oct 16, 2015
Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand
| Oct 14, 2015
Allergan releasing generic version of Invega in U.S.
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
